12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·03/24/2026 17:05:47
Listen to the news
Gainers
ENvue Medical (NASDAQ:FEED) shares increased by 59.4% to $2.28 during Tuesday's regular session. The company's market cap stands at $1.5 million.
Sol-Gel Technologies (NASDAQ:SLGL) stock increased by 33.68% to $88.5. The company's market cap stands at $184.4 million. As per the news, the Q4 earnings report came out 3 days ago.
Quantum BioPharma (NASDAQ:QNTM) stock moved upwards by 25.04% to $3.88. The market value of their outstanding shares is at $11.9 million.
CollPlant Biotechnologies (NASDAQ:CLGN) shares increased by 18.61% to $0.72. The market value of their outstanding shares is at $7.7 million.
YD Bio (NASDAQ:YDES) stock increased by 17.56% to $7.63. The market value of their outstanding shares is at $457.6 million.
Assertio Holdings (NASDAQ:ASRT) shares rose 15.46% to $16.16. The company's market cap stands at $90.2 million.
Losers
Outlook Therapeutics (NASDAQ:OTLK) shares decreased by 37.8% to $0.2 during Tuesday's regular session. The company's market cap stands at $23.5 million.
ImmunityBio (NASDAQ:IBRX) stock declined by 24.68% to $7.08. The company's market cap stands at $9.6 billion.
Achieve Life Sciences (NASDAQ:ACHV) shares decreased by 22.77% to $3.13. The market value of their outstanding shares is at $215.5 million. The company's, Q4 earnings came out today.
Artelo Biosciences (NASDAQ:ARTL) shares decreased by 22.2% to $5.96. The company's market cap stands at $5.4 million.
bioAffinity Technologies (NASDAQ:BIAF) stock declined by 21.78% to $3.7. The company's market cap stands at $21.2 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.